Orchard Hotel Singapore Sets New Standard in Hospitality Excellence with the Introduction of Aiello Voice Assistant (AVA)

SINGAPORE, June 18, 2024 /PRNewswire/ -- Aiello is excited to announce the introduction of its cutting-edge Aiello Voice Assistant (AVA) to the Singapore hospitality market, debuting exclusively at The Orchard Hotel Singapore. This AI-powered device connects guests with hotel staff and provides data-driven insights to enhance customer service and streamline operations. As AVA makes its first appearance in Singapore, Orchard Hotel Singapore leads the way for Millennium Hotels and Resorts in offering innovative guest experiences.

Established in the late 1950s and reaching a milestone in 1978 with its contemporary twin-tower design featuring 656 rooms, Orchard Hotel Singapore has long been a symbol of luxury and excellence on Orchard Road. Its iconic clock tower and prime location have made it a favorite among travelers seeking an unforgettable stay.

Guests at Orchard Hotel Singapore, a flagship property of Millennium Hotels and Resorts, will now benefit from AVA, their personal guide to amenities, services, and local recommendations. Embracing modernity, the hotel has replaced all telephone handsets, enabling guests to enjoy a hands-free stay facilitated by AVA for all communication needs. Acting as an in-room assistant, AVA responds promptly to voice commands, allowing guests to effortlessly connect with other rooms or contact the front desk.

"Our commitment to innovation and exceptional guest experiences is unwavering," said Jacqueline Ho, General Manager at Orchard Hotel Singapore. "The integration of AVA is a transformative step, combining state-of-the-art technology with personalized service to enhance guest convenience and comfort while reinforcing our leadership in the hospitality industry."

"We're not just introducing a voice assistant; we're integrating AI seamlessly into the existing hotel technology ecosystem," said Mr Vic Shen, CEO and Co-founder of Aiello. "Being the first in Singapore is just the beginning – our focus is on providing a holistic and technologically advanced guest experience that aligns with Orchard Hotel Singapore's legacy of excellence."

About Aiello

Aiello is a leading provider of Voice AI in the hospitality industry. Its flagship product, Aiello Voice Assistant, is a multi-award-winning talk & touch voice AI technology solution aimed at streamlining hotel operations, enhancing the guest experience, and generating insights about customer behavior. The state-of-the-art Aiello Voice Assistant is designed to elevate the guest experience with its unique AI-powered features and capabilities. Since 2019, Aiello Voice Assistant has been deployed in over 100 hotels, encompassing 10,000 rooms, and has answered over 14 million inquiries from 2.5 million end users in Chinese, Japanese, Thai, and English.

Learn more at Aiello's official website: https://aiello.ai/ 

About The Orchard Hotel Singapore

Home to 656 rooms and suites in characteristically unique twin buildings, the legendary Orchard Hotel Singapore is located at the heart of the city's premier shopping and entertainment district. Enlivened and refurbished to epitomize warm Asian hospitality with Signature Class amenities, Orchard Hotel Singapore offers a 25m outdoor pool, fitness studio, and close proximity to the Singapore Botanic Gardens, a UNESCO World Heritage Site. Comprehensive conference and banquet facilities include one of Singapore's largest pillar-free grand ballrooms with two floor-to-ceiling LED walls, statement lighting, and state-of-the-art audio-visual capabilities. A diverse array of signature cuisines at the hotel's award-winning dining outlets, including the enhanced Hua Ting Restaurant and The Orchard Cafe, ensure an exceptional culinary experience.

Orchard Hotel Singapore
442 Orchard Road, Singapore 238879
Hotel Website: www.orchardhotel.com.sg 

For further information, please contact:

Amy Lai
Marketing Manager, Aiello
E-mail: amy.lai@aiello.ai 

Amy Ang
Director of Marketing Communications, Orchard Hotel Singapore
E-mail: amy.ang@millenniumhotels.com 

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Orchard Hotel Singapore Sets New Standard in Hospitality Excellence with the Introduction of Aiello Voice Assistant (AVA)

Orchard Hotel Singapore Sets New Standard in Hospitality Excellence with the Introduction of Aiello Voice Assistant (AVA)

POMONA, Calif., June 27, 2024 /PRNewswire/ -- Amsino Medical Group ("Amsino"), a global provider of medical consumable devices, is pleased to announce the closing of a substantial investment by Novo Tellus, a leading investment firm specialising in long-term investments in the global supply chain.

Novo Tellus is deeply familiar with Amsino, having previously partnered with Amsino to create substantial growth between 2011 and 2017. Amsino's management team and Novo Tellus aim to work closely again to grow Amsino's global production, R&D, and commitment to quality to deliver better and better solutions to customers around the world.

"We're excited to renew a long-term partnership with Novo Tellus" said Dr. Richard Y. Lee, Chairman and CEO of Amsino Medical Group, noting that "Novo Tellus has proven itself as a growth partner for Amsino before, and shares our fundamental commitment to delivering dependable innovation and value to our customers around the world."

"We are already working with Novo Tellus to build Amsino into a next-generation global medical supplier. We're expanding our production facilities in the US and growing our supply chain to deliver more solutions, closer to market, for our customers. We're proud of the long-term relationships we have with healthcare customers around the world, and we're investing in research and advanced manufacturing to bring better and better solutions to market over time," added Dr. Lee.

Novo Tellus Managing Partner Loke Wai San said, "we've been long-term believers in Amsino's approach of delivering critical medical consumables to valued customers around the world. Today, as the global supply chain shifts in response to economic and geopolitical changes, we've listened to the market, and we see great strategic opportunity with growing Amsino's existing US production to serve more customers more deeply here in the domestic market."

Reflecting on Amsino's global prospects, Robert Chen (Operating Partner) and Pei Shan Wong (Senior Vice President) at Novo Tellus noted that "Amsino has always been a global company, and even as we grow our US operations in support of our US customers, we're looking to expand Amsino's global footprint and operations. The global supply chain now demands more of suppliers: more products, more manufacturing locations, greater availability, and a shorter supply chain. With its US headquarters, established branded offerings, and deep experience in US and Asia operations, Amsino is strategically positioned to grow into a leading supplier of diversified medical consumables worldwide."

The investment was made with all equity and no debt from Novo Tellus investment funds, and closed in June 2024, with Novo Tellus and Amsino already working actively to build the Company's future together.

About Amsino Medical Group

Amsino Medical Group, headquartered in Pomona, USA, is renowned for its comprehensive portfolio of medical devices, including urological, infusion therapy, and patient care products. With a strong emphasis on quality and innovation, Amsino has established itself as a trusted partner for healthcare providers worldwide. To learn more about partnering with Amsino, visit amsino.com.

About Novo Tellus

Novo Tellus is a private equity firm focused on building lasting technology and industrial companies in Southeast Asia. The firm is distinguished by its deep insight into shifts in the global technology ecosystem, and by its active and empathic partnerships with management teams to build lasting businesses and superior investment returns. To learn more about partnering with Novo Tellus, visit novotellus.com. 

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Amsino Medical Group announces transformational investment from Novo Tellus